Patent · US Active

Crystalline forms of a succinate salt of 7-cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7H-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid dimethylamide

US12390468B2 · kind B2 · utility

0Cited by

8References

1Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Arnaud GRANDEURY · Helfrantzkirch, FR
Nilesh PATEL · Ahmedabad, IN
Frank Schaefer · Lörrach, DE
Daniel Zimmermann · Basel, CH

Key dates

Filing date	Jan 23, 2020
Grant date	Aug 19, 2025
Priority date	—
Expiry date	Sep 4, 2042

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07B2200/13
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are new crystalline form(s) of succinate salt(s) of 7-Cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7H-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid dimethylamide (also known as ribociclib), pharmaceutical compositions comprising the same, methods of treatment using the same and methods of making the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.